Biotechnology in Denmark

Antag Therapeutics

Antag Therapeutics is a biotechnology company pioneering personal and flexible obesity treatment through GIP receptor antagonism. Antag’s lead molecule AT-7687 is specifically designed to target and deactivate the GIP receptor, a genetically-validated pathway that contributes to fat storage, insulin resistance, and metabolic dysfunction – and is mechanistically distinct from GLP-1 therapies. Antag’s GIPR antagonist approach stems from the work of the esteemed research teams of Professors Jens Juul Holst and Mette Rosenkilde, two co-founders of the business. Antag’s vision is that all people living with obesity, diabetes and overweight have a personal treatment option that goes beyond weight loss to improve long-term health, without having to compromise on tolerability.

11 to 50 staff

Cmbio

At Cmbio, we are innovators at the forefront of microbiome science and multi-omics research. Our team of over 100 experts spans microbiology, bioinformatics, metabolomics, molecular biology, and data science, bringing unparalleled expertise to advance the understanding and impact of the microbiome in global health. With labs in the US and EU and a local presence across the US, EU, and APAC regions, we are dedicated to creating breakthrough tools and analytical techniques that set new standards for the field. Together, we drive innovation to transform health and sustainability Our Services > Metagenomics Microbial strain characterization, shotgun and long-read metagenomics, marker gene analysis, microbiome profiling, absolute abundance quantification, and direct-to-consumer testing.> Metabolomics Untargeted and targeted metabolomics panels for detailed metabolic insights.> Other Omics Services Metatranscriptomics, transcriptomics, proteomics, and sampling kit development with project handling.> Advanced Analytics Biostatistics, machine learning and AI, integrative systems biology, multi-omics integration, strain tracking, and engraftment Expertise Areas > Human Health Gut, digestive, and metabolic conditions; women’s health; oral health; skin health and personal care; infant health; nutrition; neurology; mental health; immuno-oncology; microbial therapeutics (FMT and probiotics); infectious diseases; antimicrobial resistance (AMR); clinical trials; regulatory expertise; and personal testing.> Agriculture & Animal Health Agriculture, aquaculture, companion animals, AMR surveillance, and disease monitoring.> Environmental Applications Wastewater analysis, soil health monitoring, and bioremediation.> Industrial Applications Production safety, contaminant tracking, and microbial strain characterization.

51 to 200 staff

Sustainable Bio Solutions

Sustainable Bio Solutions vision is to become a leading biogas platform in Denmark and expand into other clean energy processes as well. The company's initial focus is on the Aabenraa biogas AD facility and ensuring its success before further expansion in Denmark and beyond.

11 to 50 staff

Cymab

Reshaping the future for patients with non-immunogenic tumors.

1 to 10 staff

Immumap Services - Out Of Business March 2022

ImmuMap Services is dedicated to advancing the use and quality of flow cytometry based monitoring of cellular immunity. We offer a flexible, cost-effective expert service for assessment and analysis of immune cells that are essential for determining immune recognition in health and disease. Our business is founded on four pillars. • Quality assured immune assessment by flow cytometry. • Expert guidance in collection, preservation and storage of biological samples for immune monitoring by flow cytometry. • High-throughput, multiplex MHC/peptide epitope mapping. • Training in immune assessment by flow cytometry. We work to the highest standards, use quality validated reagents and take advantage of our proven expertise in immune analysis by flow cytometry in the fields of cancer, infectious diseases and autoimmunity. ImmuMap Services excel by applying state-of-the-art technologies for discovery of new MHC/peptide epitopes in the fields of immuno oncology, vaccine- and immunotherapy as well as autoimmune diseases. We offer services at all levels from basic research and early discovery to clinical trial settings.

1 to 10 staff

Stipe Therapeutics

STipe Therapeutics is a privately held biotechnology company with a vision to become a leader in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The Company was spun out from Aarhus University, Denmark in 2018 and concluded a EUR 20 million a Series A financing in September 2019. JOB RECRUITMENT SCAM ALERT STipe Therapeutics is aware of a job recruitment scam involving fraudulent human resources recruiters contacting job seekers. The scam includes requesting personal information, promising or requesting money to purchase office equipment, and interacting and conducting false interviews via social media platforms. Please note STipe Therapeutics does not utilize social media platforms to conduct formal job interviews or extend employment offers with job seekers. We encourage job seekers to be aware of this scam and remain vigilant while searching for a job with STipe Therapeutics.

11 to 50 staff

Danish Bio - Dansk Biotek

DANSK BIOTEK is an active trade organisation which is in a continuous dialogue with the Danish authorities and who is recognised as an authority regarding biotechnology in the public debate. DANSK BIOTEK has furthermore taken steps to increase the public knowledge about modern biotechnology. The organisation publishes articles, participates in political meetings and in the public debate and teaches in biotech research conditions, genetic modification, ethical matters, etc. DANSK BIOTEK has an influence on decisions regarding state funds for innovative research and entrepreneurial activities and has contributed to the wording of rules and regulations regarding biotechnological patenting, research and production in Denmark and Europe. We also participate actively in biotech analyses as for instance the Analysis regarding Conditions for the Danish Capital. Furthermore, DANSK BIOTEK is collaborating with The Danish Association of the Pharmaceutical Industry (LIF) about clinical research in Denmark.

1 to 10 staff

Danish Malting Group A S

1 to 10 staff

Projekt Salt

Project SALT is an enterprise that combines biotechnology and the craft of traditional spirits production. The company was founded in 2013 and after a year of R&D projekt SALT launched NORDIC SAKE, which is the first in the world liquor based on open water seaweed plants. SALT is a abbreviation of Skovgaard Aller Tang as a reference to the founding partners Lasse Skovgaard Jensen and Uffe Bjørn Hørby Aller and the main focus of the enterprise, which is to develop and mature high value products of seaweed (tang in Danish).

1 to 10 staff

Tetrapharm

TETRAPHARM is a Danish biopharmaceutical company that specializes in the development of pharmaceutical drugs aimed at the central nervous system and the immune system to treat neurological diseases and mental health disorders. In addition to a strong R&D pipeline, TETRAPHARM offers a suite of tailored end-to-end CDMO services that leverages the company's proprietary drug delivery technology, ZYNDIKATE®.

51 to 200 staff

Microbe Biosolutions Aps

Hos Microbe Biosolutions udvikler vi avancerede mikrobielle løsninger og biologiske filtreringsteknologier, der forbedrer ydeevnen i spildevands, biogas- og industrielle systemer. Vores tilgang er forankret i naturlige, ikke-GMO-bakterier – omhyggeligt udvalgt for deres evne til at nedbryde organiske forbindelser, neutralisere skadelige biprodukter og genoprette den mikrobielle balance.

1 to 10 staff

Kosan Teknova

11 to 50 staff